FNY Investment Advisers’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-200
Closed 592
2022
Q4
$0 Hold
200
﹤0.01% 541
2022
Q3
$0 Hold
200
﹤0.01% 673
2022
Q2
$0 Hold
200
﹤0.01% 731
2022
Q1
$0 Sell
200
-7,000
-97% -$20.3K ﹤0.01% 765
2021
Q4
$26K Buy
7,200
+7,000
+3,500% +$42.9K 0.01% 308
2021
Q3
$1K Sell
200
-1,061
-84% -$9.08K ﹤0.01% 644
2021
Q2
$16K Sell
1,261
-9,791
-89% -$96.2K 0.01% 539
2021
Q1
$83K Buy
+11,052
New +$125K 0.03% 347
2020
Q4
Sell
-66,600
Closed -$829K 791
2020
Q3
$829K Sell
66,600
-36,900
-36% -$408K 0.35% 74
2020
Q2
$1.16M Buy
+103,500
New +$1.11M 0.67% 32

Other funds holding CLOV

FNY Investment Advisers's CLOV Position: Q1 2023 in Review

FNY Investment Advisers sold out of Clover Health Investments (CLOV) in Q1 2023, closing a stake of 200 shares.

FNY Investment Advisers first reported a position in CLOV in Q2 2020 and held it in 10 quarters. The position peaked at $1.16M in Q2 2020. 157 funds tracked by Wall St. Rank hold CLOV as of Q1 2023.

  • FNY Investment Advisers reported no remaining Clover Health Investments position as of Q1 2023 after selling out during the quarter.
  • FNY Investment Advisers sold 200 Clover Health Investments shares in Q1 2023.
  • FNY Investment Advisers first reported a position in Clover Health Investments in Q2 2020 and held it in 10 quarters.
  • FNY Investment Advisers's Clover Health Investments position peaked at $1.16M in Q2 2020.
  • 157 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2023.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.